Current Research Projects
The Critical Care Research team is currently participating in the following clinical trials. Please click on the name of the trial to see the study summary:
Department of Anesthesiology
The success rate of ultrasound guided intercostal and inguinal nerve blocks. A Case report series.
A Randomized, Double-blind, Placebo Controlled Efficacy, Safety, and Tolerability Study of up to 20 mL of DFA-02 in Patients Undergoing Abdominal Surgery.
EP Vent 2 – A Phase II study of Mechanical Ventilation Directed by Transpulmonary Pressures.
Effects of a Systematic Team Approach to Guide Early Mobilization in Surgical Intensive Care Unit Patients.
A Prospective Clinical Evaluation of Biomarkers of Traumatic Brain Injury (ALERT-TBI)
Department of Medicine
Vaccine Research
Immune Response to Viral Infection.
Immune Responses to Vaccinia Virus Vaccine.
Immune Responses to Flavivirus Vaccines.
Immune Responses Induced by Different Manufacturers of Influenza Vaccines.
Department of Pediatrics
Determination of Bromide Elimination Rate in Cystic Fibrosis (CF) Patients and Healthy Controls.
A Phase 3, Randomized Double-Blind, Placebo-Controlled, Multicenter Study of Aztreonam for Inhalation Solution (AZLI) in a Continuous Alternating Therapy (CAT) Regimen of Inhaled Antibiotics for the Treatment of Chronic Pulmonary Pseudomonas aeruginosa Infection in Subjects with Cystic Fibrosis. Protocol Number: GS-US-205-0170.
A Phase 3, Randomized, Double‑Blind, Placebo‑Controlled, Parallel‑Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del‑CFTR Mutation – Protocol Number VX-809-104